Quotes: US MENA   Enter Symbol: NewsLetter: Search: advanced

Bionomics on path to U.S. trial of anti-anxiety drug  Join our daily free Newsletter

MENAFN - ProactiveInvestors - Australia - 08/11/2012

No. of Ratings : 0
Add to Mixx!


 


(MENAFN - ProactiveInvestors - Australia) Bionomics' (ASX: BNO) licensee Ironwood Pharmaceuticals has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a clinical trial of anti-anxiety drug candidate IW-2143.

This paves the way for Ironwood to begin phase one studies of IW-2143 in healthy volunteers.

Highlighting the market potential of an anti-anxiety drug, annual sales of treatments for anxiety and related conditions are around US12 billion.

Preclinical studies conducted by Bionomics suggest that the drug has antianxiety activity and promotes neurite outgrowth.

In the U.S. alone, anxiety disorders affect 40 million Americans each year and while there are therapies available, there remains a significant unmet need.

IW-2143 has the potential to fill a need in this market as an anxiety drug that may not have the sedation, withdrawal syndrome or memory impairment reported with other therapies.

Bionomics is well-funded to continue development of its broad pipeline of products, with over A13 million in cash at the end of the September quarter.

The company is an emerging biotech with global operations in Australia, Europe and the United States.

Bionomics is targeting multi-billion dollar market opportunities in solid tumour oncology, central nervous system, and immune diseases.

The company has a significant partnership with Ironwood Pharmaceuticals for the development of BNC210 for the treatment of anxiety and depression.

The partnership includes up to US345 million in upfront, development (clinical trials) and regulatory milestone payments and royalties on net sales of products incorporating BNC210 (IW-2143).

US13 million is anticipated to January 2014 and Ironwood will fund all clinical trials and other development activities.

 






  MENA News Headlines


 






Google

 
 

Middle East North Africa - Financial Network

MENAFN News Market Data Countries Tools Section  
 

Middle East North Africa - Financial Network
Arabic MENAFN

Main News
News By Industry
News By Country
Marketwatch News
UPI News
Comtex News

IPO News
Islamic Finance News
Private Equity News

How-To Guides
Technology Section

Travel Section

Search News

Market Indices
Quotes & Charts

Global Indices
Arab Indices

US Markets Details

Commodoties

Oil & Energy

Currencies Cross Rates
Currencies Updates
Currency Converter

USA Stocks
Arab Stocks
 

Algeria 
Bahrain 
Egypt 
Iraq
Jordan 
Kuwait 
Lebanon
Morocco 
Oman 
Palestine
Qatar 
Saudi Arabia 
Syria
Tunisia 
UAE 
Yemen

Weather
Investment Game
Economic Calendar
Financial Glossary

My MENAFN
Portfolio Tracker

Voting

Financial Calculators

RSS Feeds [XML]

Corporate Monitor

Events

Real Estate
Submit Your Property

Arab Research
Buy a Research

Press Releases
Submit your PR

Join Newsletters


 
© 2000 menafn.com All Rights Reserved.  Terms of Service | Privacy Policy | Contact Us | Advertise | About MENAFN | Career Opportunities | Feedback | Help